McKesson announces OCM solutions to support community-based oncology practices
Comprehensive solution includes services, expertise and technology to support oncology practices. Read More »
Comprehensive solution includes services, expertise and technology to support oncology practices. Read More »
McKesson Patient Relationship Solutions (MPRS) was a finalist in the eyeforpharma Philadelphia Awards 2016. Read More »
The annual spring conference featured solutions to the changing landscape in health care delivery systems. Read More »
Trial data on Verseon's anti-coagulant drug family presented in Stockholm last week. Read More »
Amgen recently announced its win against Sanofi and Regeneron Pharmaceuticals. Read More »
McKesson recently announced that it has been awarded a $139 million, five-year contract from the Department of Defense and the Defense Health Agency for its patient engagement and interoperable secure messaging solution, RelayHealth. Read More »
One pharmaceutical company executive stated that the challenges retail and outpatient pharmacies face in regards to the reimbursement and regulatory environment can be solved by technology. Read More »
Rich Pharmaceuticals Inc. announced this week that CMIC ASIA-PACIFIC PTD. LTD., an Asian contract research organization (CRO), will run the first phase of an upcoming oncology clinical. Read More »
Blue Cross and Blue Shield of Illinois (BCBSIL) and Illinois Cancer Specialists (ICS) have announced the very first oncology intensive medical home (IMH) pilot program in Illinois. Read More »
Amgen and UCB have announced the results of the Phase 3 trial for romosozumab. Read More »
McKesson announced this week that it has launched its disaster recovery service that will help health care organizations uphold their mission-critical capabilities when disasters strike. Read More »
Amgen has announced that it will present 19 abstracts associated with its cardiovascular portfolio that will include new data from the evaluation of Repatha (evolocumab) at the American College of Cardiology’s 65th Annual Scientific Session (ACC 16). Read More »
Amgen and UCB have announced positive high quality results from the pivotal Phase 3 placebo-controlled study evaluatIng the efficiency and safety of romosozumab in treating men with osteoporosis (BRIDGE) trial. Read More »
Walgreens and OptumRx have announced a partnership that will result in the creation of a new pharmacy solution program aimed at changing prescription drug needs to benefit the consumer and help employers, health plans and members receive higher health outcomes and save more. Read More »
Amgen has announced that its supplemental Biologics License Application (sBLA) for the extended use of Enbrel (etanercept) in the treatment of chronic severe plaque psoriasis in pediatric patients has been accepted for review by the U.S. Food and Drug Administration (FDA). Read More »
McKesson has announced the release of Conserus Imaging Fellow. Read More »
The US Oncology Network has announced the launch of a new groundbreaking program that was developed to aid oncologists from around the country prepare for the execution of the new Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) and other alternate payment models. Read More »
Verseon Corp. has released new data for a promising class of anticoagulants that was presented at the Third International Conference on Heart & Brain (ICHB) in Paris at the end of February. Read More »
Opiant Pharmaceuticals Inc. announced this week that it has received $2.5 million from Adapt Pharma Ltd. as a milestone payment following Adapt’s first commercial sale of NARCAN Nasal Spray. Read More »
Halozyme Therapeutics Inc. announced today that it has selected Jim Daily to join its board of directors. Read More »